Poster and Platform Presentations

Functional correlation of brain loci during cognitive tasks in multiple sclerosis.

Helekar SA, Shin JC, Mattson BJ, Bartley K, Stosic M, Saldana-King T, Montague PR, Hutton GJ

Deep brain stimulation in multiple sclerosis-related Holmes' tremor.

Bernitsas E, Hutton GJ, Rivera VM

Effects of natalizumab on relapses and MRI outcomes in Hispanic patients with relapsing multiple sclerosis.

Herbert J, Rivera V, Ford C, Pace A, Hyde R

Final results from the Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis study.

Rivera V, Weinstock-Guttman B, Beagan J, Al-Sabbagh A, Bennett R, Dangond F

>> View platform presentation

Clinical and radiographic improvement of an acutely aggressive case of multiple sclerosis treated with cyclophosphamide.

Avila M, Prieto PG, Robles L, Hutton GJ, Rivera VM

Prevalence of sleep disorders in multiple sclerosis.

Avila M, Robles L, Prieto P, Bernitsas E, Stosic M, Hutton GJ, Rivera VM

Spasmodic dysphonia in MS: A rare symptom or a possible association?

Bernitsas E, Hutton GJ, Rivera VM

Seizures in MS patients: A retrospective study.

Bernitsas E, Stosic M, Hutton GH, Rivera VM

HALT-MS--Intense immunosuppression and stem cell transplantation for RRMS.

Hutton GJ, Bowen J, Forman S, Frohman E, Griffith L, Kraft G, Muraro P, Openshaw H, Popat U, Racke M, Sayre P, Stuve O, Wundes A, Nash R

Long-term sc IFN beta-1a treatment in RRMS: Cumulative dose effects.

Jeffery D, Rivera VM

Continuous vs non-continuous long-term sc IFN beta-1a treatment in RRMS.

Rivera VM, Jeffery D

Difusse white matter abnormalities and neurologic manifestations in a patient with anti-ro positive antibodies. Case Report..

Robles L, Prieto P, DeAlvare L, Hutton GJ, Rivera VM

Occurrence of herpes zoster in multiple sclerosis patients treated with natalizumab.

Robles L, Prieto P, Rivera VM, Hutton GJ

A post-hoc analysis of cumulative dose effects of subcutaneous interferon beta-1a on clinical and MRI outcomes in relapsing-remitting multiple sclerosis: Results over the long term.

Jeffery D, Rivera V

Long-term effects of interferon beta-1a dose on relapse rate in relapsing-remitting multiple sclerosis: Results from a post- hoc analysis of PRISMS study data.

Jeffery D, Rivera V

HALT MS – Phase II clinical trial of high dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation for active relapsing- remitting multiple sclerosis.

Wundes A, Bowen J, Kraft G, Hutton G, Openshaw H, Forman S, Frohman E, Griffith L, Muraro P, Racke M, Sayre P, Stuve O, Popat U, Nash R

Marburg's disease and neuromyelitis optica in brother/sister.

Bernitsas E, Hutton GJ, Rivera VM

Menstrual cycle and menopause in patients with multiple sclerosis. How do these affect the symptoms of disease?

Avila M, Suarez GA, Brandt D, Ramirez J, Hutton GJ, Rivera VM

Longitudinal individualized analysis of computer-based cognitive rehabilitation in multiple sclerosis.

Chaliman RT, Perez FI, Suarez GA, Rivera VM, Hutton GJ

RENEW study update XVIII: Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis.

Rivera V, AL-Sabbagh A, Bennett R, Coyle P, Elias S, Mikol D, Panitch H, Rolak LA, Sheremata W, Weinstock-Guttman B, Fox E, for the RENEW Study Group

Magnetic resonance imaging findings in patients with clinically isolated syndrome suggestive of multiple sclerosis.

Suarez GA, Avila M, Brandt D, Rivera VM, Hutton GJ

Silent MRI white matter lesions in patients with CIS suggestive of multiple sclerosis.

Suarez-Zambrano GA, Ramirez J, Avila M, Brandt D, Escobar BH, Hutton GJ, Rivera VM

Site performance in an investigator-run multiple sclerosis clinical trial.

Cohen J, Imrey P, Calabresi P, Chakraborty S, Edwards K, Eickenhorst T, Felton W, Fisher E, Fox R, Goodman A, Hara-Cleaver C, Hutton G, Mandell B, Scott T, Zhang H for the ACT

Phase II clinical trial (HALT-MS: Immune tolerance network) of high dose immunosuppressive therapy (HDIT) and autologus hematopoetic stem cell transplantation (AHSCT) for active relapsing-remitting (RR) multiple sclerosis (MS): Early results.

Kraft GH, Bowen JD, Openshaw H, Forman SJ, Frohman EM, Griffith LM, Hutton GJ, Muraro PA, Popat U, Racke MK, Sayre P, Stuve O, Wundes A, Nash RA

Frequency and severity of restless legs syndrome in multiple sclerosis: A population study from southeast Texas.

Suarez-Zambrano GA, Pena JA, Avila M, Hutton GJ, Rivera VM

Multiple sclerosis and antiphospholipid syndrome: Case report.

Avila M, Ramirez J, Suarez-Zambrano GA, Hutton GJ, Rivera VM

Encefalomielitis diseminada recurrente y multifásica reporte de 2 casos.
[Recurrent Disseminated Encephalomyelitis: Report of 2 Cases]

Avila M, Suarez-Zambrano GA, Ramirez J, Hutton GJ, Rivera VM

Experience with natalizumab in a group of ms patients from southeast Texas.

Suarez-Zambrano GA, Escobar BH, Avila M, Ramirez J, Hutton GJ, Rivera VM

Recurrent disseminated encephalomyelitis: Report of 2 cases.

Hutton GJ, Avila M, Suarez-Zambrano GA, Ramirez J, Rivera VM

Is restless legs syndrome more frequent and severe in the multiple sclerosis population? Study in multiple sclerosis patients from southeast Texas.

Hutton GJ, Suarez-Zambrano GA, Jafree I, Landero S, Avila M, Rivera VM

Experiencia con natalizumab en 40 pacientes con esclerosis multiple exacerbacion remision.

Suarez-Zambrano GA, Avila M, Landero S, Jafree I, Escobar BH, Ramirez J, Brandt D, Hutton GJ, Rivera VM

Multiple sclerosis and other autoimmune diseases.

Jafree I, Hashmi K, Landero S, Suarez G, Hutton GJ, Rivera VM

Behavior of multiple sclerosis during pregnancy and after delivery.

Landero S, Rivera VM, Hutton GJ, Suarez-Zambrano GA, Ramirez J

A phase II study of high-dose immunosuppressive therapy (HDIT) using carmustine, etoposide, cytarabine, and melphalan (beam) + thymoglobulin, and autologous CD34+ hematopoietic stem cell transplant (HCT) for the treatment of poor prognosis multiple sclero

Nash R, Openshaw H, Bowen JD, Forman SJ, Stuve O, Hutton GJ, Popat U, Wundes A, Kraft G

Frequency and severity of restless legs syndrome in ms patients from southeast Texas.

Suarez-Zambrano GA, Landero S, Jafree I, Hutton GJ, Rivera VM

Multiple sclerosis in African Americans: A cohort from southeast Texas.

Suarez-Zambrano GA, Landero S, Jafree I, Hutton GJ, Rivera VM

Computer-assisted cognitive rehabilitation in patients with multiple sclerosis.

Suarez-Zambrano GA, Perez F, Avila M, Hutton GJ, Rivera VM

Results of the Avonex Combination Trial (ACT).

Cohen J, Calabresi P, Eickenhorst T, Edwards K, Felton W, Fisher E, Fox R, Goodman A, Hara-Cleaver C, Hutton G, Imrey P, Mandell B, Scott T, Zhang H

Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis: The RENEW study.

Rivera VM, Al-Sabbagh A, Bennett R, Coyle P, Mikol D, Panitch H, Fox E, Rolak L, Sheremata W, Elias S

Angioplasty and stenting in symptomatic intracraneal stenosis.

Avila M, De la Maza M, Martinez Ponce de Leon A

Endovascular coil treatment for rupture and unrupture brain aneurisms.

Avila M, De la Maza M, Martinez Ponce de Leon A

Rehabilitación cognitiva asistida por computadora en pacientes con esclerosis múltiple.

Suarez-Zambrano GA, Perez F, Avila M, Hutton GJ, Rivera VM

Endovascular coiling for ruptured and unruptured intracranial aneurysms.

Avila M, De la Maza M, Martinez Ponce de Leon A

Intracranial angioplasty and stenting for symptomatic and asymptomatic intracranial stenosis.

Avila M, De la Maza M, Martinez Ponce de Leon A

Rationale, design, and baseline data for the Avonex Combination Trial (ACT).

Cohen J, Calabresi P, Edwards K, Eickenhorst T, Felton W, Fisher E, Fox R, Goodman A, Hara-Cleaver C, Hutton G, Imrey P, Mandell B, Scott T, Zhang H

Intracranial angioplasty and stenting for symptomatic middle cerebral artery stenosis.

Avila M, Valderrama C, De la Maza M, Martinez Ponce de Leon A, Dondis D

The spectrum of clinical and radiological characteristics of acute disseminated encephalomyelitis.

De la Maza M, Escobar A, Rivera V, Dondis D, Avila M, Valderrama C

Caracterizacion de sindromes clinicos de comportamiento similar a esclerosis multiple.

Ordoñez L, Skromne E, Rivera-Olmos VM

The spectrum of clinical and radiological characteristics of acute disseminated encephalomyelitis.

Avila M, De la Maza M, Dondis D

Morbidity and mortality rate in carotid artery angioplasty and stenting.

Avila M, De la Maza M, Gonzalez Camid F, Martinez Ponce de Leon A, Dondis D, Valderrama C

Intracraneal angioplasty and stenting for symptomatic middle cerebral artery stenosis.

Avila M, De la Maza M, Martinez Ponce de Leon A, Dondis D

The spectrum of clinical and radiological characteristics of acute disseminated encephalomyelitis: Report of 3 cases.

Avila M, Dondis D, De la Maza M

Combinduction therapy with mitoxantrone and methylprednisolone for aggressive forms of multiple sclerosis in patients actively treated with large freacuent doses of interferon beta 1a.

Dondis D, Avila M, De la Maza M